A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.

Shuyi WuMeina LvFuxin MaZhang FeilongGuanhua FangJin-Hua Zhang

Published in: European journal of clinical pharmacology (2023)

Based on nine risk factors, the Alfalfa-Warfarin-GIB score was constructed to predict the risk of warfarin-related major GIB. The newly developed Alfalfa-Warfarin-GIB score has a better predictive value than the HAS-BLED score and may be an effective tool to help reduce the occurrence of major GIB in patients on warfarin.

Keyphrases

atrial fibrillation
venous thromboembolism
direct oral anticoagulants
end stage renal disease
risk factors
ejection fraction
oral anticoagulants
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
risk assessment